Pitango VC
Pitango is a venture capital firm that partners with founding teams across company lifecycles via three dedicated funds (First, Growth, HealthTech). The firm provides capital and a value-add platform including operational support, network access and sector resources. Pitango highlights a global reach with local roots and publishes resources such as a Growth Playbook and a Sustainability Knowledge Hub.
Services
Equity funding via sector funds
Direct equity investments through three Pitango funds: First (early-stage), Growth (scale-stage) and HealthTech (health-focused opportunities).
Value-add platform and operational support
Non-financial support offerings referenced on the site include a Value-Add Platform, venture partners, fund operations and a support team intended to provide portfolio companies with strategic guidance, recruitment and operational resources.
Sector resources and published knowledge
Public resources referenced on the site include a Growth Playbook and a Sustainability Knowledge Hub intended to support portfolio growth and ESG-related topics.
Networking and introductions
Access to Pitango’s founder and operator network, plus introductions to strategic partners, customers and follow-on investors (implied by site sections referencing venture partners, support team and portfolio networks).
Sector-specific mentoring (HealthTech)
Dedicated HealthTech fund and a HealthTech team (Managing Partner | HealthTech) to support clinical, regulatory and commercialization needs for health-focused portfolio companies.
portfolio
Selected companies listed on Pitango's portfolio pages (entries below).
Equity funding via sector funds
Direct equity investments through three Pitango funds: First (early-stage), Growth (scale-stage) and HealthTech (health-focused opportunities).
Value-add platform and operational support
Non-financial support offerings referenced on the site include a Value-Add Platform, venture partners, fund operations and a support team intended to provide portfolio companies with strategic guidance, recruitment and operational resources.
Sector resources and published knowledge
Public resources referenced on the site include a Growth Playbook and a Sustainability Knowledge Hub intended to support portfolio growth and ESG-related topics.
Networking and introductions
Access to Pitango’s founder and operator network, plus introductions to strategic partners, customers and follow-on investors (implied by site sections referencing venture partners, support team and portfolio networks).
Sector-specific mentoring (HealthTech)
Dedicated HealthTech fund and a HealthTech team (Managing Partner | HealthTech) to support clinical, regulatory and commercialization needs for health-focused portfolio companies.
portfolio
Selected companies listed on Pitango's portfolio pages (entries below).
Portfolio
Selected by TIME Magazine as one of the TIME100 Most Influential Companies; customers include US Air Force, NASA, Uber. Reported Series C growth (> $100M raised referenced on company page).
#Weather Intelligence Platform
Mobile app tracking and attribution analytics platform; reported surpassing $150M ARR; referenced fundraising to unicorn valuation.
#Mobile attribution and analytics
AI systems focused on natural language understanding and generation.
#Artificial intelligence / natural language
Develops TCR therapies; FDA IND clearance for a program referenced on the company page.
#T cell target discovery / immuno-oncology
Clinical-stage company developing treatments for respiratory viruses and high-consequence viral pathogens.
#Biopharmaceuticals (viral therapeutics)
Developed intra-oral scanners and CAD/CAM solutions for restorative dentistry.
#Dental restorative products / CAD/CAM scanners
Selected by TIME Magazine as one of the TIME100 Most Influential Companies; customers include US Air Force, NASA, Uber. Reported Series C growth (> $100M raised referenced on company page).
#Weather Intelligence Platform
Mobile app tracking and attribution analytics platform; reported surpassing $150M ARR; referenced fundraising to unicorn valuation.
#Mobile attribution and analytics
AI systems focused on natural language understanding and generation.
#Artificial intelligence / natural language
Develops TCR therapies; FDA IND clearance for a program referenced on the company page.
#T cell target discovery / immuno-oncology
Clinical-stage company developing treatments for respiratory viruses and high-consequence viral pathogens.
#Biopharmaceuticals (viral therapeutics)
Developed intra-oral scanners and CAD/CAM solutions for restorative dentistry.
#Dental restorative products / CAD/CAM scanners